Portfolio company
Biotia
United States · £6.3m raised
Raised
£6.3m
Latest stage
Series A
Rounds recorded
1
Backed by
5 investors
Sectors
About
This company develops genomic sequencing software and diagnostic tests to identify infectious diseases for hospitals, researchers and patients.
SourceFunding history · 1
Similar companies
IDbyDNA
This company develops metagenomics software and diagnostic tests to identify pathogens and microorganisms for clinical laboratories, healthcare providers and researchers.
Delve Bio
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Informuta
Informuta develops a predictive software platform using genomic sequencing and artificial intelligence to forecast antibiotic resistance in bacteria for healthcare providers.
Claryx
Claryx develops a genomic surveillance platform that sequences pathogen DNA to detect and trace infection outbreaks for hospitals and healthcare systems.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
